Skip to content
10-K

Annual Report

ROCHESTER MEDICAL CORPORATION

0001047469-12-011322

← back to feed
Filed
Dec 19, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Dec 7, 2012 12.14M sh
Shares Diluted FY 2012 · Sep 30, 2012 12.34M sh
Shares Diluted FY 2012 · Sep 30, 2011 12.22M sh
Shares Diluted FY 2012 · Sep 30, 2010 12.18M sh
Stock Repurchased FY 2012 · Sep 30, 2012 $1.09M
Stock Repurchased FY 2012 · Sep 30, 2011 $2.51M
Stock Repurchased FY 2012 · Sep 30, 2010 $1.2M
Capex FY 2012 · Sep 30, 2012 $1.52M
Capex FY 2012 · Sep 30, 2011 $1.76M
Capex FY 2012 · Sep 30, 2010 $1.76M
Cash And Equivalents FY 2012 · Sep 30, 2012 $13.92M
Cash And Equivalents FY 2012 · Sep 30, 2011 $8.72M
Cash And Equivalents FY 2012 · Sep 30, 2010 $4.55M
Cash And Equivalents FY 2012 · Sep 30, 2009 $6.37M
Stockholders Equity FY 2012 · Sep 30, 2012 $68.3M
Stockholders Equity FY 2012 · Sep 30, 2011 $65.98M
Stockholders Equity FY 2012 · Sep 30, 2010 $68.89M
Stockholders Equity FY 2012 · Sep 30, 2009 $68.82M
Current Liabilities FY 2012 · Sep 30, 2012 $6.5M
Current Liabilities FY 2012 · Sep 30, 2011 $23.6M
Current Assets FY 2012 · Sep 30, 2012 $44.61M
Current Assets FY 2012 · Sep 30, 2011 $57.81M
Total Assets FY 2012 · Sep 30, 2012 $75.93M
Total Assets restated FY 2012 · Sep 30, 2011 $90.47M
Eps Diluted FY 2012 · Sep 30, 2012 $0.08
Eps Diluted FY 2012 · Sep 30, 2012 $0.17
Eps Diluted FY 2012 · Jun 30, 2012 $0.04
Eps Diluted FY 2012 · Mar 31, 2012 $0.05
Eps Diluted FY 2012 · Dec 31, 2011 −$0.01
Eps Diluted FY 2012 · Sep 30, 2011 $0.03
Eps Diluted FY 2012 · Sep 30, 2011 −$0.11
Eps Diluted FY 2012 · Jun 30, 2011 −$0.02
Eps Diluted FY 2012 · Mar 31, 2011 −$0.10
Eps Diluted FY 2012 · Dec 31, 2010 −$0.01
Eps Diluted FY 2012 · Sep 30, 2010 −$0.02
Eps Basic FY 2012 · Sep 30, 2012 $0.09
Eps Basic FY 2012 · Sep 30, 2012 $0.17
Eps Basic FY 2012 · Jun 30, 2012 $0.04
Eps Basic FY 2012 · Mar 31, 2012 $0.05
Eps Basic FY 2012 · Dec 31, 2011 −$0.01
Eps Basic FY 2012 · Sep 30, 2011 $0.03
Eps Basic FY 2012 · Sep 30, 2011 −$0.11
Eps Basic FY 2012 · Jun 30, 2011 −$0.02
Eps Basic FY 2012 · Mar 31, 2011 −$0.10
Eps Basic FY 2012 · Dec 31, 2010 −$0.01
Eps Basic FY 2012 · Sep 30, 2010 −$0.02
Sga Expense FY 2012 · Sep 30, 2012 $8.17M
Sga Expense restated FY 2012 · Sep 30, 2011 $8.5M
Sga Expense FY 2012 · Sep 30, 2010 $6.39M
Rd Expense FY 2012 · Sep 30, 2012 $1.19M
Rd Expense FY 2012 · Sep 30, 2011 $1.01M
Rd Expense FY 2012 · Sep 30, 2010 $1.24M
Operating Income FY 2012 · Sep 30, 2012 $1.69M
Operating Income FY 2012 · Sep 30, 2012 $3.21M
Operating Income FY 2012 · Jun 30, 2012 $713K
Operating Income FY 2012 · Mar 31, 2012 $834K
Operating Income FY 2012 · Dec 31, 2011 −$21K
Operating Income FY 2012 · Sep 30, 2011 $588K
Operating Income FY 2012 · Sep 30, 2011 −$1.68M
Operating Income FY 2012 · Jun 30, 2011 −$491K
Operating Income FY 2012 · Mar 31, 2011 −$1.31M
Operating Income FY 2012 · Dec 31, 2010 −$465K
Operating Income FY 2012 · Sep 30, 2010 $208.56K
Gross Profit FY 2012 · Sep 30, 2012 $8.48M
Gross Profit FY 2012 · Sep 30, 2012 $30.82M
Gross Profit FY 2012 · Jun 30, 2012 $7.63M
Gross Profit FY 2012 · Mar 31, 2012 $7.61M
Gross Profit FY 2012 · Dec 31, 2011 $7.11M
Gross Profit FY 2012 · Sep 30, 2011 $7.56M
Gross Profit restated FY 2012 · Sep 30, 2011 $26.65M
Gross Profit FY 2012 · Jun 30, 2011 $7.13M
Gross Profit FY 2012 · Mar 31, 2011 $6.46M
Gross Profit FY 2012 · Dec 31, 2010 $5.5M
Gross Profit restated FY 2012 · Sep 30, 2010 $20.04M
Cost Of Revenue FY 2012 · Sep 30, 2012 $30.87M
Cost Of Revenue restated FY 2012 · Sep 30, 2011 $26.72M
Cost Of Revenue restated FY 2012 · Sep 30, 2010 $21.51M
Short Term Debt FY 2012 · Sep 30, 2011 $17.86M